Status:

COMPLETED

IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

Lead Sponsor:

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Collaborating Sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Papilloma Virus, Human

Eligibility:

All Genders

Brief Summary

This study is being done to evaluate how long the immune response from the Human Papilloma Virus (HPV) vaccine you / your child received persists. The immune response occurred after immunization and i...

Detailed Description

Genital Human Papilloma Virus (HPV) infection is the most common sexually transmitted infection (STI) in the United States and worldwide. Over 50% of sexually active adolescents will become infected w...

Eligibility Criteria

Inclusion

  • Previous enrollment in P1047
  • Completion of the P1047 scheduled vaccine doses for their designated arm.
  • Parent or legal guardian able and willing to provide signed informed consent
  • Subjects should be between 1 and 2 years following their last HPV vaccination.

Exclusion

  • Any clinically significant diseases (other than HIV infection) or clinically significant findings during the screening medical history or physical examination that, in the investigator's opinion, would compromise the outcome of this study.
  • Administration of a globulin-containing product within 90 days prior to enrollment.
  • Receipt of an additional dose of Merck HPV vaccine other than that administered for the P1047 study.
  • Receipt of GSK HPV vaccine.

Key Trial Info

Start Date :

May 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2013

Estimated Enrollment :

97 Patients enrolled

Trial Details

Trial ID

NCT01206556

Start Date

May 1 2010

End Date

August 1 2013

Last Update

April 1 2015

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

Miller Children's Hospital Long Beach (5093)

Long Beach, California, United States, 90806

2

USC/Los Angeles County Medical Center NICHD CRS (5048)

Los Angeles, California, United States, 90033

3

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601)

Los Angeles, California, United States, 90095

4

Univ of California, San Diego (4601)

San Diego, California, United States, 92103

IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody | DecenTrialz